6,869 Shares in McKesson Corporation $MCK Acquired by Silvant Capital Management LLC

Silvant Capital Management LLC acquired a new stake in McKesson Corporation (NYSE:MCK) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 6,869 shares of the company’s stock, valued at approximately $5,190,000.

Other large investors have also recently made changes to their positions in the company. University of Texas Texas AM Investment Management Co. purchased a new position in McKesson in the 4th quarter worth about $25,000. Swiss RE Ltd. purchased a new stake in McKesson in the 4th quarter valued at about $26,000. State of Wyoming purchased a new stake in McKesson in the 2nd quarter valued at about $29,000. Kingdom Financial Group LLC. purchased a new position in shares of McKesson during the fourth quarter worth approximately $33,000. Finally, Birchwood Financial Partners Inc. purchased a new position in shares of McKesson during the fourth quarter worth approximately $33,000. 85.07% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

MCK has been the topic of several research analyst reports. Wells Fargo & Company increased their price objective on McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a research note on Tuesday, August 11th. Evercore reiterated an “outperform” rating on shares of McKesson in a report on Thursday, August 6th. UBS Group increased their price target on McKesson from $1,050.00 to $1,080.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Citigroup raised their price target on McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research note on Friday, July 24th. Finally, Royal Bank Of Canada initiated coverage on McKesson in a report on Wednesday. They issued a “sector perform” rating and a $845.00 price objective for the company. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, McKesson presently has an average rating of “Moderate Buy” and a consensus price target of $973.44.

Insider Buying and Selling

In other McKesson news, Director Bradley E. Lerman sold 301 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 133 shares of the stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $764.00, for a total transaction of $101,612.00. Following the sale, the chief accounting officer directly owned 632 shares of the company’s stock, valued at approximately $482,848. The trade was a 17.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 29,049 shares of company stock valued at $22,530,626 over the last three months. Corporate insiders own 0.06% of the company’s stock.

McKesson Stock Down 1.5%

Shares of NYSE:MCK opened at $841.21 on Friday. The firm has a 50 day moving average of $819.40 and a 200 day moving average of $843.73. The company has a market capitalization of $98.08 billion, a price-to-earnings ratio of 22.51, a price-to-earnings-growth ratio of 1.68 and a beta of 0.30. McKesson Corporation has a 52 week low of $673.38 and a 52 week high of $999.00.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.56 by $0.37. The business had revenue of $105.38 billion for the quarter, compared to analysts’ expectations of $103.88 billion. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%.The business’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same quarter last year, the firm earned $8.26 EPS. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, sell-side analysts expect that McKesson Corporation will post 44.65 EPS for the current year.

McKesson Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be paid a $0.94 dividend. This represents a $3.76 annualized dividend and a yield of 0.4%. This is a boost from McKesson’s previous quarterly dividend of $0.82. The ex-dividend date is Tuesday, September 1st. McKesson’s payout ratio is presently 10.06%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.